{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:37:19Z","timestamp":1790375839983,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020950","name":"Department of Pathology, Northwestern University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-21-1-0916"],"award-info":[{"award-number":["W81XWH-21-1-0916"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ajpath.2025.01.013","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T11:11:29Z","timestamp":1740049889000},"page":"1013-1030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Interferon-\u03b3\/Janus Kinase 1\/STAT1 Signaling Represses Forkhead Box A1 and Drives a Basal Transcriptional State in Muscle-Invasive Bladder Cancer"],"prefix":"10.1016","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8990-5399","authenticated-orcid":false,"given":"Shamara S.","family":"Lawrence","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2587-7100","authenticated-orcid":false,"given":"Hironobu","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2383-2240","authenticated-orcid":false,"given":"Lauren","family":"Shuman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay D.","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4286-8492","authenticated-orcid":false,"given":"Monika","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory S.","family":"Yochum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6058-6291","authenticated-orcid":false,"given":"Xue-Ru","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2938-6627","authenticated-orcid":false,"given":"Hikmat A.","family":"Al-Ahmadie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua I.","family":"Warrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6114-6714","authenticated-orcid":false,"given":"Vonn","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"DeGraff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2025.01.013_bib1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","article-title":"Clonal heterogeneity and tumor evolution: past, present, and the future","volume":"168","author":"McGranahan","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2025.01.013_bib2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41591-021-01233-9","article-title":"Intratumoral heterogeneity in cancer progression and response to immunotherapy","volume":"27","author":"Vitale","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2025.01.013_bib3","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.3390\/cancers13215297","article-title":"Tumor heterogeneity and consequences for bladder cancer treatment","volume":"13","author":"Lavallee","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ajpath.2025.01.013_bib4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.eururo.2018.09.003","article-title":"Intratumoral heterogeneity of bladder cancer by molecular subtypes and histologic variants","volume":"75","author":"Warrick","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajpath.2025.01.013_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nm.3984","article-title":"Pan-cancer analysis of the extent and consequences of intratumor heterogeneity","volume":"22","author":"Andor","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2025.01.013_bib6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.urolonc.2018.11.015","article-title":"Molecular tumor heterogeneity in muscle invasive bladder cancer: biomarkers, subtypes, and implications for therapy","volume":"40","author":"da Costa","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.ajpath.2025.01.013_bib7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1200\/JOP.19.00215","article-title":"Management of urothelial bladder cancer in clinical practice: real-world answers to difficult questions","volume":"15","author":"Mar","year":"2019","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.ajpath.2025.01.013_bib8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41585-020-0304-1","article-title":"Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes","volume":"17","author":"Meeks","year":"2020","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.ajpath.2025.01.013_bib9","doi-asserted-by":"crossref","first-page":"6575","DOI":"10.1038\/s41467-022-34251-3","article-title":"FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation","volume":"13","author":"Warrick","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2025.01.013_bib10","doi-asserted-by":"crossref","first-page":"7920","DOI":"10.1038\/s41467-022-35644-0","article-title":"Author correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation","volume":"13","author":"Warrick","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2025.01.013_bib11","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.21037\/tau.2020.03.13","article-title":"Tumor heterogeneity in muscle-invasive bladder cancer","volume":"9","author":"Kang","year":"2020","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.ajpath.2025.01.013_bib12","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1038\/s41467-020-16162-3","article-title":"Epithelial plasticity can generate multi-lineage phenotypes in human and murine bladder cancers","volume":"11","author":"Sfakianos","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2025.01.013_bib13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10555-024-10172-z","article-title":"Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance","volume":"43","author":"Bhat","year":"2024","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.ajpath.2025.01.013_bib14","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1158\/0008-5472.CAN-23-1067","article-title":"Lineage plasticity: the new cancer hallmark on the block","volume":"84","author":"Mehta","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2025.01.013_bib15","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1158\/2159-8290.CD-23-0225","article-title":"The transcriptional and epigenetic landscape of cancer cell lineage plasticity","volume":"13","author":"Davies","year":"2023","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ajpath.2025.01.013_bib16","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"Bladder cancer molecular taxonomy group: a consensus molecular classification of muscle-invasive bladder cancer","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajpath.2025.01.013_bib17","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2025.01.013_bib18","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.cell.2018.07.036","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"174","author":"Robertson","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2025.01.013_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/srep38531","article-title":"FOXA1, GATA3 and PPAR[gamma] cooperate to drive luminal subtype in bladder cancer: a molecular analysis of established human cell lines","volume":"6","author":"Warrick","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2025.01.013_bib20","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/s41388-019-1063-4","article-title":"Hypermethylation of FOXA1 and allelic loss of PTEN drive squamous differentiation and promote heterogeneity in bladder cancer","volume":"39","author":"Osei-Amponsa","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2025.01.013_bib21","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.3390\/cells11111802","article-title":"Immune microenvironment of muscular-invasive urothelial carcinoma: the link to tumor immune cycle and prognosis","volume":"11","author":"Stakhovskyi","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ajpath.2025.01.013_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000162","article-title":"Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy","volume":"8","author":"Eckstein","year":"2020","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ajpath.2025.01.013_bib23","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1186\/s12967-019-02146-5","article-title":"The dynamics of the inflammatory response during BBN-induced bladder carcinogenesis in mice","volume":"17","author":"Degoricija","year":"2019","journal-title":"J Transl Med"},{"key":"10.1016\/j.ajpath.2025.01.013_bib24","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","article-title":"Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer","volume":"8","author":"Xue","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ajpath.2025.01.013_bib25","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.2174\/0929867328666201207202012","article-title":"Targeting the JAK\/STAT signaling pathway for breast cancer","volume":"28","author":"Shao","year":"2021","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ajpath.2025.01.013_bib26","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1126\/science.abn0478","article-title":"Lineage plasticity in prostate cancer depends on JAK\/STAT inflammatory signaling","volume":"377","author":"Chan","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2025.01.013_bib27","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.3390\/genes14061141","article-title":"JAK\/STAT signaling and cervical cancer: from the cell surface to the nucleus","volume":"14","author":"Valle-Mendiola","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ajpath.2025.01.013_bib28","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1111\/jcmm.17228","article-title":"JAK-STAT core cancer pathway: an integrative cancer interactome analysis","volume":"26","author":"Erdogan","year":"2022","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.ajpath.2025.01.013_bib29","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1111\/jcmm.17863","article-title":"MTHFD2 promotes PD-L1 expression via activation of the JAK\/STAT signalling pathway in bladder cancer","volume":"27","author":"Li","year":"2023","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.ajpath.2025.01.013_bib30","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.21037\/atm-21-4192","article-title":"CALD1 promotes the expression of PD-L1 in bladder cancer via the JAK\/STAT signaling pathway","volume":"9","author":"Li","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.ajpath.2025.01.013_bib31","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fmolb.2020.00218","article-title":"RAC3 promotes proliferation, migration and invasion via PYCR1\/JAK\/STAT signaling in bladder cancer","volume":"7","author":"Cheng","year":"2020","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.ajpath.2025.01.013_bib32","doi-asserted-by":"crossref","first-page":"13949","DOI":"10.1111\/jcmm.16003","article-title":"IGF2BP3 facilitates cell proliferation and tumorigenesis via modulation of JAK\/STAT signalling pathway in human bladder cancer","volume":"24","author":"Huang","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.ajpath.2025.01.013_bib33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat Methods"},{"key":"10.1016\/j.ajpath.2025.01.013_bib34","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq--a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ajpath.2025.01.013_bib35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ajpath.2025.01.013_bib36","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat Methods"},{"key":"10.1016\/j.ajpath.2025.01.013_bib37","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma Powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ajpath.2025.01.013_bib38","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","article-title":"voom: Precision weights unlock linear model analysis tools for RNA-seq read counts","volume":"15","author":"Law","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.ajpath.2025.01.013_bib39","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpath.2025.01.013_bib40","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2025.01.013_bib41","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","article-title":"Molecular signatures database (MSigDB) 3.0","volume":"27","author":"Liberzon","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ajpath.2025.01.013_bib42","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.ajpath.2025.01.013_bib43","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.immuni.2019.08.004","article-title":"The immune landscape of cancer","volume":"51","author":"Thorsson","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.ajpath.2025.01.013_bib44","article-title":"Robust classification of immune subtypes in cancer","author":"Gibbs","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.ajpath.2025.01.013_bib45","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1186\/1471-2105-12-480","article-title":"GC-content normalization for RNA-Seq data","volume":"12","author":"Risso","year":"2011","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.ajpath.2025.01.013_bib46","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/nbt.2931","article-title":"Normalization of RNA-seq data using factor analysis of control genes or samples","volume":"32","author":"Risso","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ajpath.2025.01.013_bib47","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.tig.2013.05.010","article-title":"Human housekeeping genes, revisited","volume":"29","author":"Eisenberg","year":"2013","journal-title":"Trends Genet"},{"key":"10.1016\/j.ajpath.2025.01.013_bib48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.ajpath.2025.01.013_bib49","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1038\/ncomms3464","article-title":"Master regulators of FGFR2 signalling and breast cancer risk","volume":"4","author":"Fletcher","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2025.01.013_bib50","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/ng.3458","article-title":"Regulators of genetic risk of breast cancer identified by integrative network analysis","volume":"48","author":"Castro","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpath.2025.01.013_bib51","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00428-017-2190-3","article-title":"FOXA1 and CK14 as markers of luminal and basal subtypes in histologic variants of bladder cancer and their associated conventional urothelial carcinoma","volume":"471","author":"Warrick","year":"2017","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ajpath.2025.01.013_bib52","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ajpath.2015.01.014","article-title":"Loss of FOXA1 drives sexually dimorphic changes in urothelial differentiation and is an independent predictor of poor prognosis in bladder cancer","volume":"185","author":"Reddy","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2025.01.013_bib53","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","article-title":"IFN[gamma]: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy","volume":"18","author":"Ivashkiv","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ajpath.2025.01.013_bib54","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.celrep.2019.04.048","article-title":"Dysregulation of EMT drives the progression to clinically aggressive sarcomatoid bladder cancer","volume":"27","author":"Guo","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.ajpath.2025.01.013_bib55","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1038\/s41467-021-22465-w","article-title":"An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer","volume":"12","author":"Lindskrog","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2025.01.013_bib56","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3906\/biy-2107-72","article-title":"Classification of bladder cancer cell lines according to regulon activity","volume":"45","author":"Eray","year":"2021","journal-title":"Turk J Biol"},{"key":"10.1016\/j.ajpath.2025.01.013_bib57","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41389-019-0178-3","article-title":"Repression of transcription factor AP-2 alpha by PPAR[gamma] reveals a novel transcriptional circuit in basal-squamous bladder cancer","volume":"8","author":"Yamashita","year":"2019","journal-title":"Oncogenesis"},{"key":"10.1016\/j.ajpath.2025.01.013_bib58","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrc2780","article-title":"Fibroblast growth factor signalling: from development to cancer","volume":"10","author":"Turner","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajpath.2025.01.013_bib59","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12943-023-01897-6","article-title":"The impact of FGFR3 alterations on the tumor microenvironment and the efficacy of immune checkpoint inhibitors in bladder cancer","volume":"22","author":"Komura","year":"2023","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ajpath.2025.01.013_bib60","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/hmg\/dds486","article-title":"Oncogenic FGFR3 gene fusions in bladder cancer","volume":"22","author":"Williams","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2025.01.013_bib61","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/s43018-022-00431-9","article-title":"Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance","volume":"3","author":"Deng","year":"2022","journal-title":"Nat Cancer"},{"key":"10.1016\/j.ajpath.2025.01.013_bib62","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/s43018-022-00458-y","article-title":"Author correction: ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance","volume":"3","author":"Deng","year":"2022","journal-title":"Nat Cancer"},{"key":"10.1016\/j.ajpath.2025.01.013_bib63","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.ccell.2022.08.010","article-title":"Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer","volume":"40","author":"Wang","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2025.01.013_bib64","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13059-021-02325-y","article-title":"Subtype-associated epigenomic landscape and 3D genome structure in bladder cancer","volume":"22","author":"Iyyanki","year":"2021","journal-title":"Genome Biol"},{"key":"10.1016\/j.ajpath.2025.01.013_bib65","first-page":"139","article-title":"Carcinogen-induced bladder cancer in the FVB mouse strain is associated with glandular differentiation and increased Cd274\/Pdl-1 expression","volume":"7","author":"Amponsa","year":"2019","journal-title":"Am J Clin Exp Urol"},{"key":"10.1016\/j.ajpath.2025.01.013_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036669","article-title":"Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation","volume":"7","author":"DeGraff","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2025.01.013_bib67","first-page":"19","article-title":"Impact of consensus molecular subtypes on survival with and without adjuvant chemotherapy in muscle-invasive urothelial bladder cancer","volume":"78","author":"Koll","year":"2024","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ajpath.2025.01.013_bib68","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","article-title":"Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy","volume":"25","author":"Choi","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2025.01.013_bib69","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13000-023-01295-y","article-title":"Immunohistochemical based molecular subtypes of muscle-invasive bladder cancer: association with HER2 and EGFR alterations, neoadjuvant chemotherapy response and survival","volume":"18","author":"Helal","year":"2023","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.ajpath.2025.01.013_bib70","doi-asserted-by":"crossref","DOI":"10.1172\/JCI147025","article-title":"FOXA1 overexpression suppresses interferon signaling and immune response in cancer","volume":"131","author":"He","year":"2021","journal-title":"J Clin Investig"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944025000689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944025000689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T20:58:11Z","timestamp":1765918691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944025000689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0002944025000689"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2025.01.013","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon-\u03b3\/Janus Kinase 1\/STAT1 Signaling Represses Forkhead Box A1 and Drives a Basal Transcriptional State in Muscle-Invasive Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2025.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}